Gentian Diagnostics ASA Statistics

Total Valuation

Gentian Diagnostics ASA has a market cap or net worth of NOK 616.89 million. The enterprise value is 529.71 million.

Market Cap	616.89M
Enterprise Value	529.71M

Important Dates

The next estimated earnings date is Wednesday, February 12, 2025.

Earnings Date	Feb 12, 2025
Ex-Dividend Date	n/a

Share Statistics

Gentian Diagnostics ASA has 15.42 million shares outstanding. The number of shares has increased by 1.88% in one year.

Current Share Class	n/a
Shares Outstanding	15.42M
Shares Change (YoY)	+1.88%
Shares Change (QoQ)	+2.98%
Owned by Insiders (%)	10.22%
Owned by Institutions (%)	36.19%
Float	7.64M

Valuation Ratios

The trailing PE ratio is 277.87 and the forward PE ratio is 39.65.

PE Ratio	277.87
Forward PE	39.65
PS Ratio	4.00
PB Ratio	3.82
P/TBV Ratio	4.56
P/FCF Ratio	20.63
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 39.63, with an EV/FCF ratio of 17.72.

EV / Earnings	238.61
EV / Sales	3.44
EV / EBITDA	39.63
EV / EBIT	72.38
EV / FCF	17.72

Financial Position

The company has a current ratio of 7.04, with a Debt / Equity ratio of 0.04.

Current Ratio	7.04
Quick Ratio	5.01
Debt / Equity	0.04
Debt / EBITDA	0.50
Debt / FCF	0.22
Interest Coverage	20.00

Financial Efficiency

Return on equity (ROE) is 1.40% and return on invested capital (ROIC) is 2.74%.

Return on Equity (ROE)	1.40%
Return on Assets (ROA)	2.43%
Return on Capital (ROIC)	2.74%
Revenue Per Employee	2.66M
Profits Per Employee	38,276
Employee Count	58
Asset Turnover	0.82
Inventory Turnover	1.62

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -3.13% in the last 52 weeks. The beta is 0.57, so Gentian Diagnostics ASA's price volatility has been lower than the market average.

Beta (5Y)	0.57
52-Week Price Change	-3.13%
50-Day Moving Average	41.02
200-Day Moving Average	44.50
Relative Strength Index (RSI)	49.49
Average Volume (20 Days)	3,094

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Gentian Diagnostics ASA had revenue of NOK 154.12 million and earned 2.22 million in profits. Earnings per share was 0.14.

Revenue	154.12M
Gross Profit	86.26M
Operating Income	7.32M
Pretax Income	2.50M
Net Income	2.22M
EBITDA	9.74M
EBIT	7.32M
Earnings Per Share (EPS)	0.14

Full Income Statement

Balance Sheet

The company has 93.80 million in cash and 6.62 million in debt, giving a net cash position of 87.18 million or 5.65 per share.

Cash & Cash Equivalents	93.80M
Total Debt	6.62M
Net Cash	87.18M
Net Cash Per Share	5.65
Equity (Book Value)	161.45M
Book Value Per Share	10.47
Working Capital	126.59M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 31.21 million and capital expenditures -1.31 million, giving a free cash flow of 29.90 million.

Operating Cash Flow	31.21M
Capital Expenditures	-1.31M
Free Cash Flow	29.90M
FCF Per Share	1.94

Full Cash Flow Statement

Margins

Gross margin is 55.97%, with operating and profit margins of 4.75% and 1.44%.

Gross Margin	55.97%
Operating Margin	4.75%
Pretax Margin	1.62%
Profit Margin	1.44%
EBITDA Margin	6.32%
EBIT Margin	4.75%
FCF Margin	19.40%

Dividends & Yields

Gentian Diagnostics ASA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.88%
Shareholder Yield	-1.88%
Earnings Yield	0.36%
FCF Yield	4.85%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Gentian Diagnostics ASA has an Altman Z-Score of 15.18.

Altman Z-Score	15.18
Piotroski F-Score	n/a